id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-3517-0001,FDA,FDA-2015-D-3517,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Draft Guidance; Availability",Notice,Notice of Availability,2015-10-27T04:00:00Z,2015,10,2015-10-27T04:00:00Z,2015-12-29T04:59:59Z,2015-12-29T22:01:04Z,2015-27269,0,0,0900006481cf151f
FDA-2015-D-3517-0002,FDA,FDA-2015-D-3517,"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act ; Draft Guidance for Industry",Other,Guidance,2015-10-27T04:00:00Z,2015,10,2015-10-27T04:00:00Z,,2019-08-22T19:09:10Z,,0,0,0900006481cf1c02